Acetilátor fenotípus vizsgálata spondylarthritis ankylopoeticában.

Translated title of the contribution: Acetylator phenotype in spondylarthritis ankylopoietica

B. Rojkovich, G. Genti, E. Borbás, G. Bálint, B. Gömör

Research output: Contribution to journalArticle

Abstract

The authors studied the distribution of acetylator phenotypes among 136 AS patients (100 male, 36 female). 67 per cent of all patients were slow acetylators, 72 per cent of the males. Both rates are higher than that of the healthy Hungarian population. The authors draw attention to the clinical importance of investigating the acetylator type before sulphasalazine treatment because it may help in prescribing the effective dose and avoiding side effects.

Original languageHungarian
Pages (from-to)2639-2641
Number of pages3
JournalOrvosi Hetilap
Volume130
Issue number49
Publication statusPublished - Dec 3 1989

Fingerprint

Ankylosing Spondylitis
Phenotype
Sulfasalazine
Population
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Rojkovich, B., Genti, G., Borbás, E., Bálint, G., & Gömör, B. (1989). Acetilátor fenotípus vizsgálata spondylarthritis ankylopoeticában. Orvosi Hetilap, 130(49), 2639-2641.

Acetilátor fenotípus vizsgálata spondylarthritis ankylopoeticában. / Rojkovich, B.; Genti, G.; Borbás, E.; Bálint, G.; Gömör, B.

In: Orvosi Hetilap, Vol. 130, No. 49, 03.12.1989, p. 2639-2641.

Research output: Contribution to journalArticle

Rojkovich, B, Genti, G, Borbás, E, Bálint, G & Gömör, B 1989, 'Acetilátor fenotípus vizsgálata spondylarthritis ankylopoeticában.', Orvosi Hetilap, vol. 130, no. 49, pp. 2639-2641.
Rojkovich B, Genti G, Borbás E, Bálint G, Gömör B. Acetilátor fenotípus vizsgálata spondylarthritis ankylopoeticában. Orvosi Hetilap. 1989 Dec 3;130(49):2639-2641.
Rojkovich, B. ; Genti, G. ; Borbás, E. ; Bálint, G. ; Gömör, B. / Acetilátor fenotípus vizsgálata spondylarthritis ankylopoeticában. In: Orvosi Hetilap. 1989 ; Vol. 130, No. 49. pp. 2639-2641.
@article{2a30b7f4256645a2bb29cf87d2c985b5,
title = "Acetil{\'a}tor fenot{\'i}pus vizsg{\'a}lata spondylarthritis ankylopoetic{\'a}ban.",
abstract = "The authors studied the distribution of acetylator phenotypes among 136 AS patients (100 male, 36 female). 67 per cent of all patients were slow acetylators, 72 per cent of the males. Both rates are higher than that of the healthy Hungarian population. The authors draw attention to the clinical importance of investigating the acetylator type before sulphasalazine treatment because it may help in prescribing the effective dose and avoiding side effects.",
author = "B. Rojkovich and G. Genti and E. Borb{\'a}s and G. B{\'a}lint and B. G{\"o}m{\"o}r",
year = "1989",
month = "12",
day = "3",
language = "Hungarian",
volume = "130",
pages = "2639--2641",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "49",

}

TY - JOUR

T1 - Acetilátor fenotípus vizsgálata spondylarthritis ankylopoeticában.

AU - Rojkovich, B.

AU - Genti, G.

AU - Borbás, E.

AU - Bálint, G.

AU - Gömör, B.

PY - 1989/12/3

Y1 - 1989/12/3

N2 - The authors studied the distribution of acetylator phenotypes among 136 AS patients (100 male, 36 female). 67 per cent of all patients were slow acetylators, 72 per cent of the males. Both rates are higher than that of the healthy Hungarian population. The authors draw attention to the clinical importance of investigating the acetylator type before sulphasalazine treatment because it may help in prescribing the effective dose and avoiding side effects.

AB - The authors studied the distribution of acetylator phenotypes among 136 AS patients (100 male, 36 female). 67 per cent of all patients were slow acetylators, 72 per cent of the males. Both rates are higher than that of the healthy Hungarian population. The authors draw attention to the clinical importance of investigating the acetylator type before sulphasalazine treatment because it may help in prescribing the effective dose and avoiding side effects.

UR - http://www.scopus.com/inward/record.url?scp=0024960814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024960814&partnerID=8YFLogxK

M3 - Article

VL - 130

SP - 2639

EP - 2641

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 49

ER -